and having received travel expenses from Boehringer Ingelheim, Eli Lilly, Johnson & Johnson Medical Devices & Diagnostics Group Latin America, Novo Nordisk, Sanofi US Services and Zealand Pharma A/S
Injectable Wegovy Wegovy also has an injectable semaglutide version that has been FDA- approved for chronic weight management
Further trials, including long-term cardiovascular outcome studies, are ongoing to assess the safety and efficacy of tirzepatide compared to other treatments for type 2 diabetes
Managing side effects with thyroid disease GLP-1 side effects can overlap with and mimic Hashimoto's symptoms, creating diagnostic confusion
Clinic Response Quality Excellent Responses are tailored, not copy-paste
Around the initial weeks of treatment, the most common side effects experienced are nausea and diarrhea